Luye Pharma Group's total assets for Q2 2024 were ¥27.20B, an increase of 6.70% from the previous quarter. HK:2186 total liabilities were ¥13.11B for the fiscal quarter, a 9.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.